Crossmark

Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP

Crossref DOI link: https://doi.org/10.1016/j.gastre.2020.08.001

Published Print: 2021-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cubiella, Joaquin

Pérez Aisa, Ángeles

Cuatrecasas, Miriam

Díez Redondo, Pilar

Fernández Esparrach, Gloria

Marín-Gabriel, José Carlos

Moreira, Leticia

Núñez, Henar

Pardo López, M. Luisa

Rodríguez de Santiago, Enrique

Rosón, Pedro

Sanz Anquela, José Miguel

Calvet, Xavier
Funding

Funding for this research was provided by:

Janssen Biotech (PI17/00837)

Abbott Fund (PI17/00837)

Pfizer (PI17/00837)

Vifor Pharma (PI17/00837)

European Regional Development Fund (PI17/00837)

Instituto de Salud Carlos III (PI17/00837)

Meso Scale Diagnostics (PI17/00837)

Allergan (PI17/00837)

Takeda Canada (PI17/00837)
License Information

Text and Data Mining valid from 2021-01-01
More Information

This article is maintained by: Elsevier

Article Title: Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2020.08.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.gastrohep.2020.08.004

Content Type: article

Copyright: © 2020 Elsevier España, S.L.U. All rights reserved.